Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of β-L-2′-deoxycytidine, a selective and specific anti-HBV agent

Antiviral Chemistry and Chemotherapy

Volumn 15, Issue 5, 2004, Pages 269-279

  Pierra, Claire ^a   Benzaria, Samira ^a   Dukhan, David ^a   Loi, Anna Giulia ^b   La Colla, Paolo ^b   Bridges, Edward ^c   Mao, John ^c   Standring, David ^c   Sommadossi, Jean Pierre ^c   Gosselin, Gilles ^a  

^a CNRS   (France)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Idenix Pharmaceuticals Inc   (United States)

Author keywords

Hepatitis B virus; Prodrugs; L 2 deoxycytidine

Indexed keywords

3',5' DI O ACETYL 2' DEOXY BETA LEVO CYTIDINE; LAMIVUDINE; N 4 ACETYL 2' DEOXY BETA LEVO CYTIDINE; N 4 [(DIMETHYLAMINO)METHYLENE] 2' DEOXY BETA LEVO CYTIDINE; PRODRUG; UNCLASSIFIED DRUG;

ACYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS B; PRIORITY JOURNAL;

EID: 7544240536     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020401500506     Document Type: Article

References (14)

1. Bhat V, Ugarkar BG, Sayeed VA, Grimm K, Kosora N, Domenico PA & Stocker E (1989) A simple and convenient method for the selective N-acylations of cytosine nucleosides. Nucleosides & Nucleotides 8:179-183.
2. Breiner RG, Rose WC, Dunn JA, MacDiarmid JE & Bardos TJ (1990) Synthesis of new nucleoside phosphoraziridines as potential site-directed antineoplastic agents. Journal of Medicinal Chemistry 33:2596-2602.
3. Bryant ML, Bridges EG, Placidi L, Faraj A, Loi A-G, Pierra C, Dukhan D, Gosselin G, Imbach J-L, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Cretton-Scott E, Schinazi RF & Sommadossi J-P (2001a) Anti-HBV specific β-L-2′-deoxynucleosides. Nucleosides, Nucleotides & Nucleic Acids 20:597-607.
4. Bryant ML, Bridges EG, Placidi L, Faraj A, Loi A-G, Pierra C, Dukhan D, Gosselin G, Imbach J-L, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Marion P, Cretton-Scott E, Schinazi R & Sommadossi J-P (2001b) Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrobial Agents & Chemotherapy 45:229-235.
5. 4-(Dialkylamino)methylene derivatives of 2′-deoxycytidine and arabinocytidine: physicochemical studies for potential prodrug applications. Journal of Pharmaceutical Sciences 83:582-586.
6. Korba E & Gerin JL (1992) Use of standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Research 19:55-70.
7. Lefebvre I, Perigaud C, Pompon A, Aubertin A-M, Girardet J-L, Kirn A, Gosselin G & Imbach J-L (1995) Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-monophosphate. Journal of Medicinal Chemistry 38:3941-3950.
8. Ling R, Mutimer D, Ahmed M, Boxall E, Elias E, Dusheiko G & Harrison T (1996) Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711-713.
9. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. Journal of Immunological Methods 65:55-63.
10. Pierra C, Dukhan D, Bryant M, Sommadossi J-P, Imbach J-L & Gosselin G (2000) L-Nucleosides as potent anti-HBV agents (Part II): large-scale stereospecific syntheses of β-L-2′-deoxycytidine and β-L-thymidine. Antiviral Research 46:A62.
11. Standring DN, Bridges EG, Placidi L, Faraj A, Loi AG, Pierra C, Dukhan D, Gosselin G, Imbach J-L, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Cretton-Scott E, Schinazi RF, Myers M, Bryant ML & Sommadossi J-P (2001) Antiviral β-L-nucleosides specific for hepatitis B virus infection. Antiviral Chemistry & Chemotherapy 12(Suppl. 1):119-129.
12. Valette G (1998) [Biotransformation et Détermination du Caractère Lipophile de Pronucléotides à Visée Antivirale: Étude par Chromatographie Liquide Hautes Performances (C.L.H.P.) et Couplage C.L.H.P./Spectrométrie de Masse]. Montpellier: Université de Montpellier II-Sciences et Techniques du Languedoc. PhD Dissertation. In French.
13. Wong DK, Cheng A, O'Rourhe K, Naylor CD, Delshy AS & Heathcole J (1993) Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Annals of Internal Medicine 119:312-323.
14. Yang H, Westland CE, Delaney WE, Heathcote EJ, Ho V, Fry J, Brosgart C, Gibbs CS, Miller MD & Xiong S (2002) Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxyl for up to 60 weeks. Hepatology 36:464-473.